Derivatives of Dihydroxypyrrolidine as Anti-Cancer Compounds
申请人:EPFL Ecole Polytechnique Fédérale de Lausanne
公开号:EP2067771A1
公开(公告)日:2009-06-10
The present invention relates to derivatives of dihydroxypyrrolidine useful in the treatment of cancer. The invention further relates to a process for making the compounds. The compounds are inhibitors of α mannosidase, and possibly, also inhibit nicotinamide phosphoribosyl transferase.